Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Biofield in $365 Million China Breast Cancer Diagnostic JV

publication date: Jul 2, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Biofield Corp. established a Chinese national healthcare joint venture built around its breast cancer diagnostic device. The JV joins Biofield and Carelife, which is operating through its appointed agent, China International Medical Exchange Ltd. Funded with approximately $363 million, the Carelife JV will open a China network of medical clinics, call centers and data centers for R&D. By 2012, Carelife expects to open more than 500 medical clinics in China’s major cities.  More details...

Stock Symbol: (Pink Sheets: BZEC) 

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...